Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
Cureus · 2026-04-12
DOI: 10.7759/cureus.106907 ↗At a glance
Fallbericht in Cureus, published on 2026-04-12. Written by Anushareddy Muddasani and 3 co-authors. Institution: Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA. 22 references. The full text is freely available in PubMed Central.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pharmacology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pathology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, USA.
Cite
APA
Muddasani, A., Hendrix, R. J., Laudadio, J., & Gentille, C. (2026). Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. https://doi.org/10.7759/cureus.106907
Vancouver
Muddasani A, Hendrix RJ, Laudadio J, Gentille C. Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. 2026. doi:10.7759/cureus.106907
BibTeX
@article{Muddasani2026,
author = {Muddasani, Anushareddy and Hendrix, Rachel J and Laudadio, Jennifer and Gentille, Cesar},
title = {Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106907}
}
EUVIMED